Cienega Medical · Since 2010
BPC-157 Peptide Therapy
Understanding BPC-157
An educational overview of BPC-157, a synthetic peptide studied in early-stage research.
Interested in BPC-157 Peptide Therapy?
BPC-157 Peptide Therapy is offered through a quick consult with our medical team, who confirm it's right for you and handle scheduling.
Call or text (323) 655-8220
Our team replies fast during clinic hours · Serving LA since 2010.
16+ Years
3 Locations
7 Days Open
BPC-157 is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
BPC-157 is a synthetic peptide studied primarily in laboratory and animal (preclinical) research. Human clinical evidence is limited. It is not approved by the U.S. Food and Drug Administration for any medical use, and in 2023 the FDA classified it as a Category 2 bulk drug substance. This page is provided for general education only.
Click on a question to see more
What is BPC-157?
BPC-157 is a synthetic peptide studied mainly in preclinical (laboratory and animal) research. Human clinical evidence is limited and no health benefits have been established. Is BPC-157 FDA-approved?
No. BPC-157 is not approved by the FDA for any use. In 2023 the FDA classified it as a Category 2 bulk drug substance, and it is not legally available for this use. Does Cienega Medical offer BPC-157?
No. Cienega Medical does not offer, sell, prescribe, or administer BPC-157. This page is provided for general educational purposes only.
Visit us near you in West Hollywood, Santa Monica, and Calabasas
In-person, physician-supervised care at all three Cienega Medical clinics.
West Hollywood 375 N. La Cienega Blvd West Hollywood, CA 90048
+1-323-655-8220